Published in World J Gastroenterol on May 07, 2013
Meta-analysis: narrow band imaging for diagnosis of gastric intestinal metaplasia. PLoS One (2014) 0.77
Diagnostic yield of the light blue crest sign in gastric intestinal metaplasia: a meta-analysis. PLoS One (2014) 0.76
Acetic Acid Enhanced Narrow Band Imaging for the Diagnosis of Gastric Intestinal Metaplasia. PLoS One (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res (1992) 12.77
Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy (2005) 3.92
Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video). Endoscopy (2004) 3.36
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology (2008) 3.18
Gastrointestinal epithelial neoplasia: Vienna revisited. Gut (2002) 2.98
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut (2010) 2.79
A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy (2006) 2.52
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96
The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter (2007) 1.77
Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet (2003) 1.48
Magnifying endoscopy combined with narrow-band imaging for differential diagnosis of superficial depressed gastric lesions. Endoscopy (2009) 1.47
Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest Endosc (2003) 1.39
Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol (2000) 1.24
Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci (1996) 1.11
Endoscopy in the diagnosis of gastritis. Diagnostic value of endoscopic criteria in relation to histological diagnosis. Endoscopy (1984) 1.10
Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol (2002) 1.07
A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions. Endoscopy (2012) 1.07
Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy. Dig Dis Sci (2010) 1.07
Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol (2009) 1.04
Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol (2012) 0.97
Chromoendoscopic observations on extension and development of fundal gastritis and intestinal metaplasia. Gastroenterology (1985) 0.91
Regional estimates of stomach cancer burden in Italy. Tumori (2007) 0.90
Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. Scand J Gastroenterol (2010) 0.86
The impact of biopsy number and site on the accuracy of intestinal metaplasia detection in the stomach A morphometric study based on virtual biopsies. Dig Liver Dis (2008) 0.81
Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking. Gac Sanit (2008) 0.80
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. N Engl J Med (2015) 6.71
Liver enzyme alteration: a guide for clinicians. CMAJ (2005) 3.42
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol (2006) 2.64
The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol (2008) 2.36
Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment. Am J Gastroenterol (2008) 2.32
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med (2008) 2.22
An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment Pharmacol Ther (2003) 2.03
A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice. J Clin Gastroenterol (2006) 1.69
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Am J Gastroenterol (2013) 1.65
Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol (2008) 1.59
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy. Liver Int (2012) 1.53
Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation. J Gastroenterol Hepatol (2012) 1.52
Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol (2012) 1.47
Identification of a lower grade muconodular subtype of gastric mucinous cancer. Virchows Arch (2004) 1.43
Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole. J Clin Gastroenterol (2006) 1.43
A predictive model identifies patients most likely to have inadequate bowel preparation for colonoscopy. Clin Gastroenterol Hepatol (2012) 1.42
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis (2011) 1.37
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group. Am J Gastroenterol (2005) 1.33
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol (2009) 1.32
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol (2011) 1.29
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28
Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology (2009) 1.24
NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20
Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer. Neoplasia (2005) 1.15
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J (2013) 1.12
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver Int (2011) 1.10
Non-erosive reflux disease is more complex than negative endoscopy only. Am J Gastroenterol (2013) 1.09
Which anticoagulant drug should be used to treat portal vein thrombosis in patients with chronic liver disease? Clin Gastroenterol Hepatol (2012) 1.07
Comment to "predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease". Dig Liver Dis (2013) 1.07
Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. Clin Oral Investig (2013) 1.06
Esophageal acid exposure still plays a major role in patients with NERD. J Gastroenterol (2013) 1.06
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. J Gastroenterol (2014) 1.04
Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol (2009) 1.03
External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02
Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections. Histochem Cell Biol (2015) 1.02
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin Gastroenterol Hepatol (2004) 1.01
Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial. Am J Gastroenterol (2009) 1.00
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse. Hepatology (2009) 1.00
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. J Med Genet (2012) 1.00
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol (2013) 1.00
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol (2008) 0.99
Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol (2009) 0.99
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology (2012) 0.99
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology (2012) 0.98
Adalimumab in active ulcerative colitis: a "real-life" observational study. Dig Liver Dis (2013) 0.98
Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci (2006) 0.97
Thrombocytopenia in liver disease. Curr Opin Hematol (2008) 0.96
IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. Int J Cancer (2009) 0.96
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int (2013) 0.94
Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis (2011) 0.94
Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis (2012) 0.93
Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin (2005) 0.93
A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy. J Clin Gastroenterol (2009) 0.91
Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition (2006) 0.90
Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford) (2013) 0.90
Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90
Functional heartburn and non-erosive reflux disease. Dig Dis (2007) 0.90
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression. Int J Cancer (2008) 0.89
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. Transl Oncol (2013) 0.88
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol (2013) 0.88
Hepatocellular carcinoma in patients with cryptogenic cirrhosis. Clin Gastroenterol Hepatol (2009) 0.87
DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant. Transpl Int (2014) 0.86
Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus. Ann N Y Acad Sci (2013) 0.86
Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol (2010) 0.85
Modulation by phenethyl isothiocyanate and budesonide of molecular and histopathologic alterations induced by environmental cigarette smoke in mice. Cancer Prev Res (Phila) (2009) 0.84
[Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis]. Recenti Prog Med (2009) 0.84
Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol (2011) 0.84
The role of Acid in functional dyspepsia. Am J Gastroenterol (2011) 0.84
Refinement and reproducibility of histologic criteria for the assessment of microscopic lesions in patients with gastroesophageal reflux disease: the Esohisto Project. Dig Dis Sci (2011) 0.84
The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (2009) 0.83
Hepatocellular carcinoma in patients without cirrhosis in Italy. Dig Liver Dis (2012) 0.83
Microscopic esophagitis and Barrett's esophagus: the histology report. Dig Liver Dis (2011) 0.83